יום שלישי, נובמבר 17, 2026 עברית|English Log in Free sign-up
LIVE
UK psychotherapy group faces regulatory probe after UKLFI complaint over anti-Israel rhetoricUS loses measles elimination status after nearly three decadesNSA's highly classified internal communications network shuts down, linked to software update – WSJUK Jewish center investigated over ad for Israeli medical clinicSpace tech firm named after Ilan Ramon raises $124 million in Series B to power orbital data centerReport: US intelligence's red line has been brokenLikud’s Ofir Katz to challenge MK Kahana for Knesset speaker roleOutgoing Health Ministry chief Moshe Bar Siman Tov presents health system dataKnesset set to vote on appointment of Yashar MK Matan Kahana as speaker'No democracy in Arab sector': Likud official says thousands of claims of election fraud unansweredSupreme Court petition seeks to halt land allocations to yeshivasFormer police spokesman slams election day arrests, accuses commissioner, police of major failuresUK psychotherapy group faces regulatory probe after UKLFI complaint over anti-Israel rhetoricUS loses measles elimination status after nearly three decadesNSA's highly classified internal communications network shuts down, linked to software update – WSJUK Jewish center investigated over ad for Israeli medical clinicSpace tech firm named after Ilan Ramon raises $124 million in Series B to power orbital data centerReport: US intelligence's red line has been brokenLikud’s Ofir Katz to challenge MK Kahana for Knesset speaker roleOutgoing Health Ministry chief Moshe Bar Siman Tov presents health system dataKnesset set to vote on appointment of Yashar MK Matan Kahana as speaker'No democracy in Arab sector': Likud official says thousands of claims of election fraud unansweredSupreme Court petition seeks to halt land allocations to yeshivasFormer police spokesman slams election day arrests, accuses commissioner, police of major failures
Business

Turkey probes Israeli pharmaceutical company Teva over claims it blocked rivals in drug market

אוג 27, 2026 ·  Source: The Jerusalem Post 82Objectivity score82/100

Turkey probes Israeli pharmaceutical company Teva over claims it blocked rivals in drug market

The Turkish investigation was opened against Teva International, its subsidiary Teva Europe, and its subsidiary in Turkey to determine whether the law was violated.

💬 רוצים להגיב ולהצטרף לדיון? הצטרפו — חינם, ומקבלים גם את הדיג׳סט השבועי.
🗞️ In-depth summary

Turkey's Competition Authority has launched an investigation into Israeli pharmaceutical company Teva, suspecting violations of local laws by hindering rivals in the drug market. The probe, initiated after a preliminary investigation, examines whether Teva restricted competition in generic drugs, potentially through strategic patent procedures and by creating a "misleading" impression on health authorities regarding product efficacy and safety. The investigation targets Teva International, Teva Europe, and its Turkish subsidiary, focusing on actions that may have prevented competitors from market entry, such as manipulating patent applications for production methods and dosages. Teva stated, "The Turkish Competition Authority's investigation concerns a past antitrust issue related to the drug Copaxone, similar to the process being conducted by the European Commission, which is currently under appeal before the European Court of Justice, and in which Teva rejects any claim of misconduct on its part." This investigation does not currently involve sanctions against Teva, which remains one of the few Israeli companies operating in Turkey amid trade embargoes.

Automatically generated summary based on the original article; quotes are from the source.
This story is based on reporting by The Jerusalem Post.
Read the full article at the source →

© All rights to the original article belong to the source. Din Online shows a headline, an excerpt and a link only. The objectivity rating is computed automatically and is an estimate only.

Related

Discussion

No comments yet — be the first to comment.

Add a comment